Stereotaxis Inc.
Organization details
- Legal name
- Stereotaxis Inc.
- Ownership
- Public
- Status
- Active
- Sector (GICS)
- Health Care
- SIC code
- 3845 — Electromedical & Electrotherapeutic Apparatus
- Jurisdiction of incorporation
- Delaware
- Headquarters city
- St.louis
- Headquarters state / province
- Missouri
- Headquarters country
- United States
- Fiscal year end
- December
- Ticker symbol
- STXS
- Primary stock exchange
- NYSE American
Identifiers
- SEC CIK
- 0001289340
- EIN
- 94-3120386
Board of directors
-
Arun Swarup Menawat · DirectorSince 2023
-
David Benfer · DirectorSince 2023
-
Myriam Curet · DirectorSince 2023
-
Nachum Shamir · DirectorSince 2024
-
Nathan Fischel · DirectorSince 2023
-
Paul J. Isaac · DirectorSince 2023
-
Robert J. Messey · DirectorSince 2023
-
Ross B. Levin · DirectorSince 2023
Director election results
Annual meeting of May 14, 2026. Support is votes for as a share of votes for and against (or withheld). Below 80% is a clear protest.
-
92.4%
-
97.5%
-
98.4%
Board connections
3 of this board's directors also sit on 6 other boards. 5 are in the same sector.
- via Arun Swarup Menawat
-
Inspire Medical Systems Inc. Same sectorvia Myriam Curet
-
MediWound Ltd. Same sectorvia Nachum Shamir
-
Mobia Medical Inc. Same sectorvia Myriam Curet
-
Nektar Therapeutics Same sectorvia Myriam Curet
-
Profound Medical Corp. Same sectorvia Arun Swarup Menawat
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
- Bought, last 12 months
- $66,600
- 2 purchases by 1 insider
- Sold, last 12 months
- $0
- 0 sales by 0 insiders
| Date | Insider | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Jul 1, 2026 | David Benfer Director | Grant or award | +43,103 | — | — |
| Jul 1, 2026 | Myriam Curet Director | Grant or award | +43,103 | — | — |
| Jul 1, 2026 | Nathan Fischel Director, 10% owner | Grant or award | +43,103 | — | — |
| Jul 1, 2026 | Ross B. Levin Director | Grant or award | +43,103 | — | — |
| Jul 1, 2026 | Arun Swarup Menawat Director | Grant or award | +43,103 | — | — |
| Jul 1, 2026 | Nachum Shamir Director | Grant or award | +43,103 | — | — |
| Jan 2, 2026 | Arun Swarup Menawat Director | Grant or award | +46,948 | — | — |
| Jan 2, 2026 | Myriam Curet Director | Grant or award | +46,948 | — | — |
| Jan 2, 2026 | David Benfer Director | Grant or award | +46,948 | — | — |
| Jan 2, 2026 | Nathan Fischel Director, 10% owner | Grant or award | +46,948 | — | — |
| Jan 2, 2026 | Ross B. Levin Director | Grant or award | +46,948 | — | — |
| Jan 2, 2026 | Nachum Shamir Director | Grant or award | +46,948 | — | — |
| Nov 17, 2025 | Paul J. Isaac Director, See Remarks | Open-market purchase | +10,000 | $2.18 | $21,800 |
| Nov 14, 2025 | Paul J. Isaac Director, See Remarks | Open-market purchase | +20,000 | $2.24 | $44,800 |
| Jul 1, 2025 | Arun Swarup Menawat Director | Grant or award | +43,668 | — | — |
Peers
Compare boardsOrganizations in the same sector, closest in location and size first.
Questions about Stereotaxis Inc.
How many directors are on Stereotaxis Inc.'s board?
Stereotaxis Inc.'s board has 8 directors: Arun Swarup Menawat, David Benfer, Myriam Curet, Nachum Shamir, Nathan Fischel, Paul J. Isaac, Robert J. Messey and Ross B. Levin.
Are Stereotaxis Inc. insiders buying or selling shares?
Over the last 12 months, Stereotaxis Inc. insiders bought $66,600 of shares in 2 purchases and made no open-market sales on the open market, as reported to the SEC on Forms 4 and 5.
Embed this board on your site
Paste this where the board should appear. It always shows the current directors and links back here.
<div data-bod-board="stereotaxis-inc"></div>
<script src="https://boardofdirectors.review/embed.js" async></script>Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.